AYTU
AYTU BIOPHARMA, INC
$2.09
-2.79%
$23.1M
No data for this timeframe.
Vol
Market Cap$23.1M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$1.2M
Inst. Activity1 buys / 1 sells
SEC Reports1
Recent Activity
Apr 21, 2026
SEC
Aytu BioPharma amended its outstanding warrants to clarify that stockholder approval cannot modify beneficial ownership
8-K — Impact 7/10
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
107,133 shares ($278.5K)
Inst.
MORGAN STANLEY — TRIM
125 shares ($325.00)
May 13, 2026
earnings_calendar
AYTU Q3 2026 Earnings Scheduled — 2026-05-13
Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$9.33 (Dec 2025)
Current $2.09
Low $7.00
Median $7.00
High $14.00
3 analysts
$7.00
$14.00
Analyst Ratings
2Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 10, 2025 | Ascendiant Capital | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.29 ▼ -45.0% | $-0.29 — $-0.29 | -280% YoY | 1 |
| Current FY | $-1.02 ▲ +30.4% | $-1.02 — $-1.02 | -789% YoY | 1 |
| Next FY | $-0.05 ▼ -129.4% | $-0.40 — $0.30 | 95% YoY | 2 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $724.3K | DOUBLED |
| TWO SIGMA INVESTMENTS, LP | $278.5K | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $233.0K | — |
| WELLS FARGO & COMPANY/MN | $330.00 | — |
| MORGAN STANLEY | $325.00 | TRIM |
6 institutional holders with $1.2M total value (475,676 shares) as of 2025-Q4. Top holders: VANGUARD, TWO, RENAISSANCE.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 278,583 | $724.3K | 58.6% | DOUBLED +898.9% |
| 2 | TWO SIGMA INVESTMENTS, LP | 107,133 | $278.5K | 22.5% | ADD +55.9% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 89,623 | $233.0K | 18.8% | — |
| 4 | WELLS FARGO & COMPANY/MN | 127 | $330.00 | 0.0% | — |
| 5 | MORGAN STANLEY | 125 | $325.00 | 0.0% | TRIM -56.3% |
| 6 | BANK OF AMERICA CORP /DE/ | 85 | $221.00 | 0.0% | TRIM -38.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | ADD | 68,736 | 107,133 | +55.9% | $278.5K | 2025-Q4 |
| MORGAN STANLEY | TRIM | 286 | 125 | -56.3% | $325.00 | 2025-Q4 |
| VANGUARD GROUP INC | DOUBLED | 27,888 | 278,583 | +898.9% | $523.7K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 35,035 | 68,736 | +96.2% | $129.2K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 35,035 | — | $76.4K | 2025-Q2 |
| UBS Group AG | DOUBLED | 262 | 3,047 | +1063.0% | $6.6K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 103 | 63 | -38.8% | $137.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | DOUBLED | 11,062 | 30,493 | +175.7% | $36.6K | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 1,496 | 262 | -82.5% | $314.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 11,062 | — | $18.5K | 2024-Q4 |
| UBS Group AG | DOUBLED | 260 | 1,496 | +475.4% | $2.5K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 440 | 290 | -34.1% | $681.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2025): 89% buy across 9 analysts — 2 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$9.33 mean target (Dec 2025)
$7.00 Low
$14.00 High
| Metric | Value |
|---|---|
| Current Price | $2.09 |
| Target Low | $7.00 |
| Target Mean | $9.33 |
| Target Median | $7.00 |
| Target High | $14.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.29 | $-0.29 | $-0.29 | -279.6% | -45.0% | 0↑ 1↓ | $0.0B | -18.0% | 1 |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | 100.0% | +100.0% | 1↑ 0↓ | $0.0B | 23.7% | 1 |
| Current FY 2026-06-30 |
$-1.02 | $-1.02 | $-1.02 | -788.5% | +30.4% | 1↑ 0↓ | $0.1B | -18.5% | 1 |
| Next FY 2027-06-30 |
$-0.05 | $-0.40 | $0.30 | 95.1% | -129.4% | — | $0.1B | 30.5% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.290 | |
| 7d ago | $-0.305 | +0.015 |
| 30d ago | $-0.200 | -0.090 |
| 60d ago | $-0.200 | -0.090 |
| 90d ago | $-0.070 | -0.220 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 10, 2025 | Ascendiant Capital | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Jan 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
AYTU Q3 2026 Earnings Scheduled — 2026-05-13